Rituxan (rituximab)
Posted: Sun Sep 03, 2017 11:37 am
Rituxan (rituximab) is an infusion used off label as an NMO attack preventative.
DESCRIPTION
Rituxan® (rituximab) is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. Rituximab has a binding affinity for the CD20 antigen of approximately 8.0 nM.
Continued at source.
http://www.rxlist.com/rituxan-drug.htm
DESCRIPTION
Rituxan® (rituximab) is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab has an approximate molecular weight of 145 kD. Rituximab has a binding affinity for the CD20 antigen of approximately 8.0 nM.
Continued at source.
http://www.rxlist.com/rituxan-drug.htm